DigraphOrganize the world
Digraph

Search

BlogRecentEverythingSign in
TB Alliance
Parent topics
  • Tuberculosis
This topic
  • Recent activity
You must be signed in to add and move topics and links.
  • How a new antibiotic destroys extremely drug-resistant tuberculosis | Ars Technica
    https://arstechnica.com/science/2019/08/how-a-new-antibiotic-destroys-extremely-drug-resistant-tuberculosis/
    2019-08 FDA approves Pretomanid Tablets in combination with bedaquiline and linezolid for treatment of XDR-TBAmikacinCapreomycinGram-negative bacteriaKanamycinLevofloxacinLinezolidPretomanidTB Alliance
  • Mumbai pharma company gets licence for breakthrough TB drug | India News - Times of India
    https://timesofindia.indiatimes.com/india/mumbai-pharma-company-gets-licence-for-breakthrough-tb-drug/articleshow/71787870.cms
    Bedaquiline-linezolid-pretomanid (BPaL)Extensively drug-resistant tuberculosis (XDR-TB)PretomanidTB Alliance
  • Stewardship / Resistance Scan for Oct 28, 2019 | CIDRAP
    http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-28-2019
    Bacterial pneumoniaBedaquiline-linezolid-pretomanid (BPaL)DelafloxacinMoxifloxacinNDM-1OXA-48TB Alliance

Terms・ Software available under the MIT license. © Eric Walker.